News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
AOL.com Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Point72 Asset Management and its related entities, including Point72 Capital Advisors, Inc. and Steven A. Cohen, have reported a beneficial ownership of 1,993,837 shares of Janux Therapeutics (JANX) common stock, representing 3.3% of the outstanding class as of June 30, 2026. This stake is …
KeyBanc analysts have issued bullish ratings for several industrial goods companies. Michael Leshock maintained a Buy rating on Firefly Aerospace, Inc. (FLY) with a Strong Buy consensus. Jeffrey Hammond reiterated a Buy rating on Janus International Group (JBI), while Sangita Jain maintained a Buy …
Janus Henderson Group Ltd. has reported beneficial ownership of 172,229 shares of Janux Therapeutics, Inc. common stock, which represents a 0.3% stake in the company. These shares are held across various client accounts managed by Janus Henderson's investment adviser subsidiaries, and the group exercises …
HC Wainwright has revised its Q3 2026 EPS estimate for Janux Therapeutics (NASDAQ:JANX) to a loss of $0.45 per share, an improvement from its previous estimate. Despite this, Janux Therapeutics recently reported quarterly earnings that fell short of expectations, with an EPS loss of …
Janus International Group has released its Q2 2026 financial results and updated investor presentations. The company submitted a current report to the SEC detailing its performance for the quarter ending July 4, 2026, including an earnings presentation and a refreshed investor presentation. These materials, …
Janus International Group, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. …
Janus International Group, Inc. filed its quarterly report on Form 10-Q with the SEC on August 11, 2026, for the fiscal quarter that ended on July 4, 2026. The article notes that additional content is available upon logging in or creating an account.
Janus Living, Inc. (NYSE:JAN) has announced a public offering of 16 million shares of its Class A-1 common stock, with underwriters having an option to purchase an additional 2.4 million shares. The senior housing REIT intends to use the proceeds for acquisitions, investment opportunities, …
Earnings Call Insights: Janus International Group (JBI) Q2 2026 MANAGEMENT VIEW * "Second quarter results reflected a continuation of the macroeconomic trends we have discussed throughout the year as the operating environment remained challenging across many of the markets we serve." (CEO & Director …
Janus International Group, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. …
This article is a transcript of the Janus International Group's Q2 2026 Earnings Call, held on August 11, 2026. It indicates that the full content is reserved for subscribers. The article also mentions that UBS adjusted Janus International Group's price target to $5.60 from …
Janus International Group (NYSE:JBI) announced its quarterly earnings, reporting an EPS of $0.17, surpassing the consensus estimate of $0.14. Despite beating earnings, the company's revenue of $233.5 million fell short of analyst estimates but showed a 2.4% year-over-year increase. Following the announcement, shares of …
HC Wainwright has lowered its FY2030 earnings per share (EPS) estimate for Janux Therapeutics (NASDAQ:JANX) to $0.97, down from $1.06, while the consensus remains a loss of $1.70 per share. This adjustment follows Janux's recent quarterly earnings report, where the company missed analyst expectations …
Janus International Group Inc. (NYSE:JBI) saw its shares drop 14% after reporting mixed second-quarter results and issuing a weaker-than-expected full-year outlook. While the company beat EPS estimates, revenue fell short, and its updated 2026 guidance for both revenue and adjusted EBITDA disappointed analysts. The …
Janus International Group reported Q2 2026 revenue of $233.5 million, a 2.4% year-over-year increase, driven by strong self-storage growth. However, profitability metrics declined, with net income falling to $10.7 million and Adjusted EBITDA decreasing by 18.0% to $40.2 million, resulting in margin compression. The …
Janus International Group, Inc. (JBI) reported Q2 adjusted EPS of $0.17 per share. The company's Q2 revenue was $233.5 million, missing the FactSet estimate of $238.8 million. Janus International also cut its 2026 revenue guidance to a range of $925 million to $945 million, …
Janus Living, Inc. (NYSE: JAN) had an SEC filing (Form S-11) go effective on August 10, 2026, at 5:30 P.M. The filing was accepted by SEC EDGAR on August 11, 2026, at 06:17 AM. The company's market capitalization is $6.58 billion, and it operates …
This article provides an overview of Janux Therapeutics Inc (JANX) stock information, including its current trading price, market capitalization, and a note that more news is coming soon. It also lists various financial and analytical tools available on the platform for users interested in …
Search by ticker symbol or company name and select a result to open its chart.